Elena P. Filipova
Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD).
Journal: ClinicoEconomics and outcomes research : CEOR
Published: November 22, 2025
Malposition of subcutaneous central venous port system in a toddler with acute lymphoblastic leukemia: A case report.
Journal: International journal of surgery case reports
Published: February 22, 2023
Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients.
Journal: Blood pressure monitoring
Published: September 10, 2020
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2020
Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide - which is the better alternative? A meta-analysis.
Journal: Systematic reviews
Published: February 06, 2020
Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis.
Journal: Journal of human hypertension
Published: March 11, 2019
Bosutinib: Valuable therapeutic option for the Bulgarian market.
Journal: Journal of cancer research and therapeutics
Published: September 11, 2018
Pioglitazone Therapy and Fractures: Systematic Review and Meta- Analysis.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: November 24, 2017
Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis.
Journal: Diabetology & metabolic syndrome
Published: July 21, 2017
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 02, 2017
Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.
Journal: Diabetology & metabolic syndrome
Published: April 06, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026